HOME >> MEDICINE >> NEWS
Association publishes blueprint to strengthen stroke care from prevention through recovery

d vice chairman of the department of emergency medicine, said tPA use for ischemic stroke is one of several recent advances in stroke treatment. Some hemorrhagic strokes can be treated effectively with surgery or catheter-based treatments that reduce disability from that condition, and remarkable advances also have been made in secondary prevention and rehabilitation in recent years, he said.

"That's why we need a system to better implement the advances that have been achieved," he said. "We tend to fixate on our own arena as either clinicians or administrators. We can each sharpen our own tools to advance stroke care, but until the many tools in the toolbox work together, we aren't optimizing our collective skills. That's what stroke systems will do."

Among suggestions in the blueprint, health professionals should identify the acute stroke treatment capabilities and limitations of all hospitals in a state or region and make that information available to primary care providers, emergency services and the public.

"This is a non-partisan document," Schwamm said. "It is not about making the teaching hospitals even more comprehensive in their stroke care. This is about equal access for all citizens to high-quality stroke care. It's critical to leverage technology to make the stroke expertise available to all, regardless of their geography or economic circumstances. If you're poor and live near a poor hospital, you shouldn't be deprived of high-quality stroke care just because your hospital can't afford or can't attract a dedicated on-site stroke neurologist."

This blueprint ideally will promote greater efficiency of care as well as the more effective application of acute treatment and secondary prevention -- such as getting people on cholesterol-lowering drugs; controlling high blood pressure, diabetes and weight; and telling them of the importance of quitting smoking and increasing exercise. This should lower the total burden of recu
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
2-Feb-2005


Page: 1 2 3 4 5

Related medicine news :

1. Awards & fellowships at the International & American Association for Dental Research General Session
2. Canadian neurologist wins highest award as American Stroke Association honors five
3. Association of herpesvirus with lung disorder questioned
4. Highlights of the December Journal of the American Dietetic Association
5. Highlights of the September Journal of the American Dietetic Association
6. Highlights of June Journal of the American Dietetic Association
7. New darifenacin data released at the American Urological Association (AUA)
8. News tips from the American Heart Association
9. The American Heart Associations new guidelines for cardiovascular disease prevention in women
10. American Stroke Associations 29th International Stroke Conference
11. American Lung Association calls on governors and legislatures to stand up for public health

Post Your Comments:
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: